Skip to Main content Skip to Navigation
Journal articles

Molecular Actions of PPARα in Lipid Metabolism and Inflammation

Abstract : Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor of clinical interest as a drug target in various metabolic disorders. PPARα also exhibits marked anti-inflammatory capacities. The first-generation PPARα agonists, the fibrates, have however been hampered by drug-drug interaction issues, statin drop-in, and ill-designed cardiovascular intervention trials. Notwithstanding, understanding the molecular mechanisms by which PPARα works will enable control of its activities as a drug target for metabolic diseases with an underlying inflammatory component. Given its role in reshaping the immune system, the full potential of this nuclear receptor subtype as a versatile drug target with high plasticity becomes increasingly clear, and a novel generation of agonists may pave the way for novel fields of applications.
Document type :
Journal articles
Complete list of metadata

Cited literature [74 references]  Display  Hide  Download
Contributor : Marie-Hélène Derudas Connect in order to contact the contributor
Submitted on : Wednesday, June 12, 2019 - 8:26:31 AM
Last modification on : Wednesday, March 23, 2022 - 3:51:04 PM


Bougarne Endocrine Review.pdf
Files produced by the author(s)




Nadia Bougarne, Basiel Weyers, Sofie J Desmet, Julie Deckers, David W Ray, et al.. Molecular Actions of PPARα in Lipid Metabolism and Inflammation. Endocrine reviews, Endocrine Society, 2018, 39 (5), pp.760-802. ⟨10.1210/er.2018-00064⟩. ⟨inserm-02153118⟩



Record views


Files downloads